Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Apotex Corp. with status Current. The shortage was first posted on Nov 1, 2023.
Shortage details
- Status
- Current
- Company
- Apotex Corp.
- Package NDC
- 60505-4741-1
- Dosage Form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 60505-4741-1)
- Initial Posting
- Nov 1, 2023